Literature DB >> 29264310

Epidemiology of Hepatitis E Virus in an Urban Community in Dhaka City.

Salimur Rahman1, Munira Jahan2, Shahina Tabassum2, Sheikh Mohammad Fazle Akbar3.   

Abstract

INTRODUCTION: Hepatitis E virus (HEV) is endemic in Bangladesh and sporadic and epidemic outbreaks of acute hepatitis E occur in this country almost regularly. Although the real magnitude of HEV prevalence has not been documented in Bangladesh, HEV infections and HEV-related acute hepatitis of Bangladeshi origin have been reported from different parts of the world.
METHODS: The study was conducted in Mirpur area of Dhaka city, which is a major residential area of the capital of Bangladesh. Three hundred adults were randomly included in the study. None had any history of jaundice or complains of liver diseases.
RESULTS: The study revealed 30% prevalence of HEV in this population. The prevalence increased with age, but there was no gender difference.
CONCLUSION: HEV is a highly prevalent disease in Bangladesh as elsewhere in the developing world. Since there is no specific treatment for HEV, improvement of personal hygiene and ensuring supply of safe food and drinking water remain most important approach to sustain the virus.How to cite this article: Rahman S, Mahtab MA, Jahan M, Tabassum S, Akbar SMF. Epidemiology of Hepatitis E Virus in an Urban Community in Dhaka City. Euroasian J Hepato-Gastroenterol 2014; 4(1):4-6.

Entities:  

Keywords:  Hepatitis E; Prevalence; Urban population.

Year:  2014        PMID: 29264310      PMCID: PMC5736947          DOI: 10.5005/jp-journals-10018-1087

Source DB:  PubMed          Journal:  Euroasian J Hepatogastroenterol        ISSN: 2231-5047


  22 in total

1.  A novel virus in swine is closely related to the human hepatitis E virus.

Authors:  X J Meng; R H Purcell; P G Halbur; J R Lehman; D M Webb; T S Tsareva; J S Haynes; B J Thacker; S U Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Phylogenetic analysis of hepatitis E virus isolates from Egypt.

Authors:  S A Tsarev; L N Binn; P J Gomatos; R R Arthur; M K Monier; H van Cuyck-Gandre; C F Longer; B L Innis
Journal:  J Med Virol       Date:  1999-01       Impact factor: 2.327

3.  A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis.

Authors:  Y Wang; R Ling; J C Erker; H Zhang; H Li; S Desai; I K Mushahwar; T J Harrison
Journal:  J Gen Virol       Date:  1999-01       Impact factor: 3.891

4.  Analysis of the complete genome of indigenous swine hepatitis E virus isolated in Japan.

Authors:  H Okamoto; M Takahashi; T Nishizawa; K Fukai; U Muramatsu; A Yoshikawa
Journal:  Biochem Biophys Res Commun       Date:  2001-12-21       Impact factor: 3.575

5.  Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus.

Authors:  S Y Hsieh; X J Meng; Y H Wu; S T Liu; A W Tam; D Y Lin; Y F Liaw
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

6.  Imported and autochthonous hepatitis E virus strains in Spain.

Authors:  M Fogeda; A Avellón; C G Cilla; J M Echevarría
Journal:  J Med Virol       Date:  2009-10       Impact factor: 2.327

7.  Population seroprevalence of hepatitis E virus antibodies in rural Bangladesh.

Authors:  Alain B Labrique; K Zaman; Zahid Hossain; Parimalendu Saha; Mohammad Yunus; Anowar Hossain; John Ticehurst; Kenrad E Nelson
Journal:  Am J Trop Med Hyg       Date:  2009-11       Impact factor: 2.345

Review 8.  Hepatitis E: review.

Authors:  T Uchida
Journal:  Gastroenterol Jpn       Date:  1992-10

9.  Hepatitis E virus is a leading cause of acute-on-chronic liver disease: experience from a tertiary centre in Bangladesh.

Authors:  Mamun-Al Mahtab; Salimur Rahman; Mobin Khan; Md Fazal Karim
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2009-02

10.  HEV infection as an aetiologic factor for acute hepatitis: experience from a tertiary hospital in Bangladesh.

Authors:  Salimur Rahman; Mobin Khan; Fazal Karim
Journal:  J Health Popul Nutr       Date:  2009-02       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.